Re-attendance and retesting between 1.5 and 12 months after a positive test
| Individuals with positive test*, n | Within 1.5–12 months of initial positive test | |||||||||
| Re-attended and retested | Re-attended but not retested | Did not re-attend | Positive at retest | |||||||
| n (%) | p Value | n (%) | p Value | n (%) | p Value | n (%) | 95% CI | p Value | ||
| Overall | 175 | 70 (40.0) | 70 (40.0) | 35 (20.0) | 10 (16.1) | 8.0 to 27.7 | ||||
| Age group, years | ||||||||||
| 16–19 | 46 | 20 (43.5) | 0.81 | 19 (41.3) | 0.78 | 7 (15.2) | 0.58 | 2 (11.8) | 1.5 to 36.4 | 0.84 |
| 20–24 | 83 | 33 (39.8) | 31 (37.3) | 19 (22.9) | 5 (17.2) | 5.8 to 35.8 | ||||
| 25–29 | 46 | 17 (37.0) | 20 (43.5) | 9 (19.6) | 3 (18.8) | 4.0 to 45.6 | ||||
| Sex | ||||||||||
| Men | 52 | 13 (25.0) | 0.01 | 22 (42.3) | 0.69 | 17 (32.7) | 0.01 | 5 (41.7) | 15.2 to 72.3 | 0.01 |
| Women | 123 | 57 (46.3) | 48 (39.0) | 18 (14.6) | 5 (10.0) | 3.3 to 21.8 | ||||
| Area of residence | ||||||||||
| Metropolitan | 114 | 50 (43.9) | 0.40 | 44 (38.6) | 0.79 | 20 (17.5) | 0.46 | 5 (11.1) | 3.7 to 24.1 | 0.05 |
| Non-metropolitan | 49 | 18 (36.7) | 20 (40.8) | 11 (22.4) | 5 (33.3) | 11.8 to 61.6 | ||||
Statistically significant p values are shown in boldface.
↵* Initial positive test between 1 January 2008 and 31 December 2008.
†Based on retest where a result is known; overall 62 (88.6%) individuals retested in 1.5–12 months have a result known.